Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2016 | 728 | 0.770 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2016 | 168 | 0.540 |
Why?
|
| Pancreatic Cyst | 1 | 2012 | 28 | 0.380 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1305 | 0.230 |
Why?
|
| MicroRNAs | 1 | 2012 | 916 | 0.230 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1670 | 0.210 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1539 | 0.190 |
Why?
|
| Lumican | 2 | 2016 | 4 | 0.150 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 9 | 0.130 |
Why?
|
| Keratan Sulfate | 1 | 2014 | 6 | 0.110 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2014 | 29 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 287 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 241 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 473 | 0.100 |
Why?
|
| Pancreatectomy | 1 | 2012 | 149 | 0.090 |
Why?
|
| Reoperation | 1 | 2012 | 852 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2012 | 1572 | 0.070 |
Why?
|
| Heterografts | 2 | 2016 | 197 | 0.060 |
Why?
|
| Phenotype | 1 | 2014 | 4526 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 7105 | 0.040 |
Why?
|
| Young Adult | 1 | 2012 | 9952 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2509 | 0.030 |
Why?
|
| Humans | 6 | 2016 | 132013 | 0.030 |
Why?
|
| Middle Aged | 2 | 2012 | 28968 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 69 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2014 | 85 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 138 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2014 | 83 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 106 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 101 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 94 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 17374 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 248 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 21406 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 370 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 1045 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2014 | 292 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 664 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1080 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 606 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 501 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 992 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 686 | 0.020 |
Why?
|
| Adult | 1 | 2012 | 31563 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1710 | 0.020 |
Why?
|
| Proteomics | 1 | 2014 | 596 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1560 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 34804 | 0.020 |
Why?
|
| Male | 2 | 2012 | 64914 | 0.020 |
Why?
|
| Female | 2 | 2012 | 70643 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 1294 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 2057 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 18478 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 1360 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1899 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3682 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 5008 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4684 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4710 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 6568 | 0.010 |
Why?
|